Department of Urology, CHU Hassane2, FEZ, Morocco.
World Journal of Advanced Research and Reviews, 2026, 30(01), 011-015
Article DOI: 10.30574/wjarr.2026.30.1.0812
Received on 21 February 2026; revised on 30 March 2026; accepted on 01 April 2026
Introduction: Bladder tumors are common and represent the second most frequent urological malignancy. They are classically considered a disease of older adults, typically occurring between 50 and 70 years of age. Their occurrence before the age of 40 is rare, accounting for only 1–4% of all cases. The natural history and prognosis of bladder tumors in young patients remain a subject of debate.
Materials and Methods: This is a retrospective, single-center study including 18 patients aged under 40 years who were managed between 2019 and 2023.
Results: Among 487 patients, 18 (3.7%) were younger than 40 years. The mean age was 34.2 years, with a male predominance (83.3%; male-to-female ratio = 5). Hematuria was present in 83.3% of cases. Non–muscle-invasive bladder tumors accounted for 61.1% of cases. Urothelial carcinoma was the predominant histological type (83.3%). The recurrence rate was 22.2%.
Conclusion: Bladder tumors in young patients are rare and generally associated with a favorable prognosis; however, long-term surveillance remains essential.
Ladder Cancer; Young Patients; Urothelial Carcinoma; Prognosis
Preview Article PDF
Youness RAJI, Mehdi SOULEIMANI, Rachid ADEHRI, Rhyan OUADDANE ALAMI, Mustapha AHSAINI, Soufiane MELLAS, Jalal Eddine EL AMMARI, Mohammed Fadl TAZI and Mohammed Jamal EL FASSI. Bladder tumors in young patients under 40 years: A retrospective study of 18 cases. World Journal of Advanced Research and Reviews, 2026, 30(01), 011-015. Article DOI: https://doi.org/10.30574/wjarr.2026.30.1.0812.